RAB5B and cancer: Leveraging extensive cancer data from the TCGA database, with a specific focus on ACC and THYM cancers, the study identified a negative correlation between RAB5B expression and the infiltration levels of NKT, CD8+T, MDSC, Tfh, and γ/δ T cells.